An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, CA andres.cardenas@berkeley.edu.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA.; Department of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, Amherst, MA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.; Division of Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME.; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.; Department of Environmental Health, Boston University School of Public Health, Boston, MA.; Joslin Diabetes Center, Harvard Medical School, Boston, MA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Authors
Cardenas Andres, Hivert Marie-France, Gold Diane R, Hauser Russ, Kleinman Ken P, Lin Pi-I D, Fleisch Abby F, Calafat Antonia M, Ye Xiaoyun, Webster Thomas F, Horton Edward S, Oken Emily
Studies
Abstract
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are suspected endocrine disruptors widely detected across populations. We examine the extent to which PFASs are associated with diabetes incidence and microvascular disease. Secondarily, we tested whether a lifestyle intervention modifies associations and decreases concentrations.